07:00 , Apr 13, 2009 |  BioCentury  |  Finance

Ebb & Flow

In its $31 million financing this month, Savient Pharmaceuticals Inc. (NASDAQ:SVNT) employed a novel warrant structure that allowed it to finance ahead of a significant binary event without having to provide an upfront premium based...
07:00 , Jun 16, 2008 |  BioCentury  |  Finance

Ebb & Flow

Invitrogen needs uplift By Stacy Lawrence Senior Writer Despite the prospect of creating a mammoth provider of reagents and systems via the acquisition of Applied Biosystems (NYSE:ABI), investors in Invitrogen (NASDAQ:IVGN) seemed uncertain about how...
00:51 , Mar 19, 2008 |  BC Extra  |  Financial News

Alimera raises $30 million, amends Medidur FA deal

Alimera (Alpharetta, Ga.) raised $30 million in a series C round. Existing investors Venrock Associates; BA Venture Partners; Domain Associates; Intersouth Partners; and Polaris Venture Partners participated in the round. Alimera will use the financing...
01:30 , Mar 9, 2007 |  BC Extra  |  Financial News

Scale closes $400M fund

Scale Venture Partners (formerly BA Venture Partners) closed its Scale Venture Partners II fund at $400 million. About one-third of the fund will be invested in healthcare companies, with individual investments of $10-$15 million. Previous...
08:00 , Jan 8, 2007 |  BioCentury  |  Finance

Ebb & Flow

Cowen was no slouch on the biotech financing front in 2006, underwriting at least $2 billion of the sector's IPOs, follow-ons and private placements/registered directs. Now, the firm hopes to add another leg to its...
02:02 , Jan 5, 2007 |  BC Extra  |  Financial News

Horizon raises $15 million

Horizon Therapeutics (Palo Alto, Calif.) raises $15 million in a series B round led by Scale Venture Partners (formerly BA Venture Partners). Existing investors Sutter Hill Ventures and Pequot Ventures also participated. Horizon's HZT-501 ,...
01:52 , Jan 4, 2007 |  BC Extra  |  Financial News

BA Venture Partners adds LPs

BA Venture Partners has taken on new institutional investors into its existing fund and is being renamed Scale Venture Partners. Original limited partner Bank of America will continue as a minority investor in Scale Venture's...
07:00 , Sep 4, 2006 |  BC Week In Review  |  Company News

Zogenix board of directors update

Zogenix Inc. , San Diego, Calif.   Business: Neurology   Appointed: Cam Garner, chairman and CEO of Verus Pharmaceuticals Inc. and chairman of Cadence Pharmaceuticals Inc., as chairman; Kurt Wheeler, a managing director at Clarus...
07:00 , Sep 4, 2006 |  BioCentury  |  Finance

Ebb & Flow

The formation of Zogenix and the company's $60 million series A round last week all come from a confluence of events related to a needleless formulation of the migraine compound sumatriptan. The story starts in...
00:36 , Aug 29, 2006 |  BC Extra  |  Financial News

Zogenix raises $60M, buys Aradigm's Intraject

Neurology company Zogenix (San Diego, Calif.) raised $60 million in a series A round led by Clarus and Domain Associates. Additional investors included BA Venture Partners; Thomas, McNerney; and Life Science Angels. Zogenix also acquired...